AGREEMENT AND PLAN OF MERGER by and among EIDOS THERAPEUTICS, INC., BRIDGEBIO PHARMA, INC. GLOBE MERGER SUB I, INC. and GLOBE MERGER SUB II, INC. Dated as of October 5, 2020Merger Agreement • October 6th, 2020 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER, dated as of October 5, 2020 (this “Agreement”), is entered into by and among Eidos Therapeutics, Inc., a Delaware corporation (the “Company”), BridgeBio Pharma, Inc., a Delaware corporation (“Parent”), Globe Merger Sub I, Inc., a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub”), and Globe Merger Sub II, Inc., a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub II” and, together with the Company, Parent and Merger Sub, the “Parties” and each, a “Party”).
